NanoString
European UPC Court of Appeal Rules for Bruker's NanoString Biz, Invalidates 10x Patent
With the decision, the 10x patent becomes invalid in France and the Netherlands, following a decision earlier this year invalidating it in Germany.
Pancreatic Cancer Spatial Single-Cell Analysis Teases out Microenvironment Responses to Treatment
Researchers found features in the pancreatic ductal adenocarcinoma microenvironment that are related to chemotherapy resistance.
Bruker Q2 Revenues Rise 17 Percent
The company's revenues climbed to $800.7 million from $681.9 million the year before, beating the consensus Wall Street estimate of $796.5 million.
Tumor Gene Expression Signature Linked to Chemotherapy Response in Colon Cancer Cases
Based on hundreds of stage II and III colon cancer samples, researchers uncovered and validated a 10-gene signature linked to adjuvant chemotherapy response.
Kidney Microenvironment, Prognostic Features Defined in Spatial Single-Cell Study
Researchers used spatial and single-cell analyses to put together a kidney cell atlas offering clues to the kidney microenvironment and disease-related fibrotic microenvironment changes.